The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is associated with an immunosuppressive tumor‐microenvironment (TME) that supports the growth of tumors and mediates tumors enabling evasion of the immune system. Expression of programmed cell death ligand 1 (PD‐L1) and loss of human leukocyte antigen (HLA) cla...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Imai, Daisuke, Yoshizumi, Tomoharu, Okano, Shinji, Uchiyama, Hideaki, Ikegami, Toru, Harimoto, Norifumi, Itoh, Shinji, Soejima, Yuji, Aishima, Shinichi, Oda, Yoshinao, Maehara, Yoshihiko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504334/
https://ncbi.nlm.nih.gov/pubmed/28602029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1087
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia